Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis Sandoz Unveils Plan For China Production And Distribution Center

This article was originally published in PharmAsia News

Executive Summary

Novartis Sandoz recently disclosed plans to make its Zhongshan company the China pharmaceutical production base, and will move its current sales center to the city to establish Sandoz China production and distribution center. Set up in Zhongshan in 2007, Novartis Sandoz focuses on pharmaceutical chemicals, capsules, tablets and repackaging of imported medicines. The company's revenue saw more than $40 million in 2008 with its production of eight main types of medicines. Novartis has identified China as the growth engine for its global expansion and top-level corporate executives will visit relevant Chinese government officials by the end of this month. (Click here for more - Chinese Language)

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts